Demographics | Our patient | Historical 1 [3] | Historical 2 [3] | Historical 3 [4] |
---|---|---|---|---|
Sex | Male | Male | Male | Male |
Age, years | 63 | 15 | 26 | 24 |
Race | Caucasian | African American | Caucasian | Caucasian |
CBC at admission | ||||
Hemoglobin 12.0–17.5 g/dl | 10.0 | 9.8 | 13.3 | 10.7 |
Platelets 140–450 × 103/μl | 235a | 76 | 101 | 130 |
White cell count 4.5–11.0 × 103/μl | 22.2 | 23.7 | 14.7 | 23.5 |
Differential count, % | ||||
Neutrophils 1.50–7.50 × 103/μl | 4.8 | 8.3 | 6.7 | Not available |
Lymphocytes 1.50–3.70 × 103/μl | 0.9 | 2.8 | 2.6 | Not available |
Monocytes 0.20–1.00 × 103/μl | 0.2 | 0.7 | 0.4 | Not available |
Eosinophils 0.00–0.50 × 103/μl | 16.2 | 11.1 | 4.9 | 18.3 |
Schistocytes | Positive | Not available | Positive | Positive |
Renal function test at admission | ||||
Creatinine 0.61–1.24 mg/dl | 1.3 | 10.9 | 2.2 | 1.81 |
GFR | 56 | Not available | 57 | 50 |
Percentage eosinophils in bone marrow | 60% | 80% | 44% | 37% |
Renal biopsy | Glomerular capillary thrombosis Mesangiolysis Endotheliosis Eosinophilic infiltrate | Arterial thrombosis Mesangiolysis Eosinophilic infiltrate | Arteriolar thrombosis Glomerular capillary thrombosis Eosinophilic infiltrate | Arteriolar thrombosis Glomerular capillary thrombosis Eosinophilic infiltrate |
Urinalysis | ||||
Proteinuria | Negative | Present | Present | Present |
Red blood cells/high-power field | 20 | 50 | Not available | 100 |
Eosinophils/high-power field | None | None | 7 | None |
Treatment | Prednisone | Prednisone Rituximab | Prednisone Imatinib | Imatinib |
Follow-up | At 2 months | At 6 months | At 12 months | At 12 months |
Creatinine 0.61–1.24 mg/dl | 1.18 | 5.2 | 1.8 | 1.7 |